-
-
-
-
-
-
-
UPDATE: Baird Upgrades Arrowhead Research (ARWR) to Outperform
-
-
-
-
-
-
-
Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
-
-
-
-
-
-
-
The Medicines Company Reports Second-Quarter 2019 Financial Results and Updates Clinical Development Program
-
-
-
-
-
-
-
Melinta Therapeutics Completes Acquisition of The Medicines Company’s Infectious Disease Portfolio
-
-
-
-
-
-
-
Medicines Co. (MDCO) Announces FDA Approval of VABOMERE
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/06: (ALQA) (SCYX) (ZUMZ) Higher; (ALNY) (TWTR) (MDCO) Lower (more...)
-
-
-
-
-
-
-
Mallinckrodt (MNK) Announces Completion of Hemostasis Drug Portfolios Acquisition from Medicines Co. (MDCO)
-
924,127 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All